Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Solifenacin, Mirabegron and Combination Therapy in Children With Overactive Bladder and Daytime Urinary Incontinence (BeDry)

NCT06551246 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT06551246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06551246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Solifenacin, Mirabegron and Combination Therapy in Children With Overactive Bladder and Daytime Urinary Incontinence (BeDry)
Lead sponsor
University of Aarhus
Phase
Phase 3
Overall status
Recruiting
Start date
June 27, 2024
Completion date
December 1, 2027
Enrollment
236 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

urinary incontinence in children